Three dementia drugs “hold promise”
Alzheimer’s Society has published a blog about the 143 drugs now in clinical trials across the globe as possible treatments for Alzheimer’s disease. The blog highlights what it regards as the three “promising” drugs, lecanemab, gantenerumab and donanemab. In September, pharma companies Eisai and Biogen announced trial results showing that lecanemab had slowed down decline…
